<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- EDGAR Online I-Metrix Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.12.8 -->
<!-- Round: 5 -->
<!-- Creation date: 2011-11-03T16:39:57Z -->
<!-- Copyright (c) 2005-2011 EDGAR Online, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2011-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:hae="http://www.haemonetics.com/20111001" xmlns:invest="http://xbrl.sec.gov/invest/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="hae-20111001.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20101002_0" unitRef="iso4217_USD" decimals="-3">5632000</us-gaap:RestructuringReserve>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0011_STD_0_20101002_0" unitRef="iso4217_USD" decimals="-3">662000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0011_STD_0_20101002_0" unitRef="iso4217_USD" decimals="-3">115049000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20101002_0_450737x445456" unitRef="iso4217_USD" decimals="-3">5632000</us-gaap:RestructuringReserve>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="shares" decimals="INF">24981455</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_22">9974000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">4185000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DeferredTaxAssetsNetCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_6">9790000</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_46">8785000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_33">110806000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_21">1353000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-5">153600000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
  <us-gaap:LongTermDebtNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_34">3332000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">3639000</us-gaap:RestructuringReserve>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_45">364726000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_7">17203000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">1541000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">1020000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_3">129242000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:Assets contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_24">823722000</us-gaap:Assets>
  <us-gaap:AccruedIncomeTaxesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_30">5361000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_39">249000</us-gaap:CommonStockValue>
  <us-gaap:InventoryNet contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_5">101444000</us-gaap:InventoryNet>
  <us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0">P1Y</us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" xsi:nil="true" id="fnid_30437403_1_37" />
  <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-5">12200000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
  <us-gaap:OtherLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_32">45703000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="shares" decimals="INF" id="fnid_30437403_1_43">24981455</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:MachineryAndEquipmentGross contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_11">132124000</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:AssetsCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_8">441100000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_31">123000</us-gaap:DeferredTaxLiabilitiesCurrent>
  <us-gaap:Goodwill contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_20">115582000</us-gaap:Goodwill>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_19">49320000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_36">13302000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:InventoryFinishedGoods contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">61810000</us-gaap:InventoryFinishedGoods>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_2">183421000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2" id="fnid_30437403_1_40">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_4">2283000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_35">18005000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_14">490069000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_15">333203000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:InventoryRawMaterials contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">35333000</us-gaap:InventoryRawMaterials>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_48">823722000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_44">304517000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:StockholdersEquity contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_47">678277000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="shares" decimals="INF" id="fnid_30437403_1_42">24981455</us-gaap:CommonStockSharesIssued>
  <us-gaap:PropertyPlantAndEquipmentOther contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_13">217471000</us-gaap:PropertyPlantAndEquipmentOther>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_18">98847000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_16">156866000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:LongTermDebtCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_27">3080000</us-gaap:LongTermDebtCurrent>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="shares" decimals="INF" id="fnid_30437403_1_41">150000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:InventoryWorkInProcess contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3">4301000</us-gaap:InventoryWorkInProcess>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_28">29759000</us-gaap:AccountsPayableCurrent>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-5">48200000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_29">26780000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <hae:TotalOtherAssets contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_23">225756000</hae:TotalOtherAssets>
  <hae:OfficeEquipmentAndInformationTechnologyGross contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_12">85347000</hae:OfficeEquipmentAndInformationTechnologyGross>
  <hae:LandBuildingsAndBuildingImprovementsGross contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0" unitRef="iso4217_USD" decimals="-3" id="fnid_30437403_1_10">55127000</hae:LandBuildingsAndBuildingImprovementsGross>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_441306x451457_451532x449846_452742x467802" unitRef="iso4217_USD" decimals="-3">1541000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_441306x451457_451532x449846_452742x468080" unitRef="iso4217_USD" decimals="-3">4185000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319" unitRef="iso4217_USD" decimals="-3">1541000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319" unitRef="iso4217_USD" decimals="-3">144576000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319" unitRef="iso4217_USD" decimals="-3">4185000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319" unitRef="iso4217_USD" decimals="-3">4185000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319" unitRef="iso4217_USD" decimals="-3">143035000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">1541000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">1541000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">4185000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">4185000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x452604" unitRef="iso4217_USD" decimals="-3">143035000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x452604" unitRef="iso4217_USD" decimals="-3">143035000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450737x445456" unitRef="iso4217_USD" decimals="-3">2983000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_450737x447194" unitRef="iso4217_USD" decimals="-3">656000</us-gaap:RestructuringReserve>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_451169x442541" unitRef="iso4217_USD" decimals="-5">3700000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="eol_PE5753----1110-Q0011_STD_0_20111001_0_456277x487715" unitRef="iso4217_USD" decimals="-5">2400000</us-gaap:LossContingencyAccrualAtCarryingValue>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20100403_0" unitRef="iso4217_USD" decimals="-3">9761000</us-gaap:RestructuringReserve>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0011_STD_0_20100403_0" unitRef="iso4217_USD" decimals="-3">903000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0011_STD_0_20100403_0" unitRef="iso4217_USD" decimals="-3">141562000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20100403_0_450737x445456" unitRef="iso4217_USD" decimals="-3">9761000</us-gaap:RestructuringReserve>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">10458000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">4174000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DeferredTaxAssetsNetCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">9674000</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">9541000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">108671000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">1291000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">154800000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
  <us-gaap:LongTermDebtNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">3966000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">3671000</us-gaap:RestructuringReserve>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">373630000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">30897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">2563000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">1273000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">127166000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:Assets contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">833264000</us-gaap:Assets>
  <us-gaap:AccruedIncomeTaxesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">6033000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">256000</us-gaap:CommonStockValue>
  <us-gaap:InventoryNet contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">84387000</us-gaap:InventoryNet>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">13400000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
  <us-gaap:OtherLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">46256000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="shares" decimals="INF">25660393</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:MachineryAndEquipmentGross contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">128612000</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:AssetsCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">448831000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">107000</us-gaap:DeferredTaxLiabilitiesCurrent>
  <us-gaap:Goodwill contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">115367000</us-gaap:Goodwill>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">43827000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">15822000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:InventoryFinishedGoods contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">53631000</us-gaap:InventoryFinishedGoods>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">196707000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD_per_shares" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">1799000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">18669000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">475684000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">320156000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:InventoryRawMaterials contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">26404000</us-gaap:InventoryRawMaterials>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">833264000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">302709000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:StockholdersEquity contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">686136000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="shares" decimals="INF">25660393</us-gaap:CommonStockSharesIssued>
  <us-gaap:PropertyPlantAndEquipmentOther contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">211455000</us-gaap:PropertyPlantAndEquipmentOther>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">101789000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">155528000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:LongTermDebtCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">913000</us-gaap:LongTermDebtCurrent>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="shares" decimals="INF">150000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:InventoryWorkInProcess contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">4352000</us-gaap:InventoryWorkInProcess>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">28323000</us-gaap:AccountsPayableCurrent>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">45900000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">27039000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <hae:TotalOtherAssets contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">228905000</hae:TotalOtherAssets>
  <hae:OfficeEquipmentAndInformationTechnologyGross contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">83258000</hae:OfficeEquipmentAndInformationTechnologyGross>
  <hae:LandBuildingsAndBuildingImprovementsGross contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">52359000</hae:LandBuildingsAndBuildingImprovementsGross>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0_441306x451457_451532x449846_452742x467802" unitRef="iso4217_USD" decimals="-3">2563000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0_441306x451457_451532x449846_452742x468080" unitRef="iso4217_USD" decimals="-3">4174000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0_450737x445456" unitRef="iso4217_USD" decimals="-3">2782000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0_450737x447194" unitRef="iso4217_USD" decimals="-3">889000</us-gaap:RestructuringReserve>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0011_STD_0_20110402_0_451169x442541" unitRef="iso4217_USD" decimals="-5">4100000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:GrossProfit contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">174217000</us-gaap:GrossProfit>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">50000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">5841000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">262000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-23826000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">442000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">837000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:ProductWarrantyAccrualPayments contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">940000</us-gaap:ProductWarrantyAccrualPayments>
  <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-5">3400000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
  <us-gaap:CostOfGoodsSold contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">155655000</us-gaap:CostOfGoodsSold>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">3234000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="pure" decimals="4">0.0243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">44286000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="shares" decimals="INF">35992</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">38518000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">1645000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">53534000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">4089000</us-gaap:ShareBasedCompensation>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD_per_shares" decimals="2">1.54</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-22143000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">6941000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-316000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-4069000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">166000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD_per_shares" decimals="2">16.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">39257000</us-gaap:NetIncomeLoss>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">1400000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">15875000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">628000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">1894000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-5">4100000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="shares" decimals="-5">800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">699000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">24088000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD_per_shares" decimals="2">1.58</us-gaap:EarningsPerShareBasic>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">24690000</us-gaap:DepreciationAndAmortization>
  <us-gaap:TaxBenefitFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">946000</us-gaap:TaxBenefitFromStockOptionsExercised>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">53092000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestPaidNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">251000</us-gaap:InterestPaidNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">329872000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-5249000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">22000</us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax>
  <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-5">1300000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
  <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-6849000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="Year" decimals="1">4.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">3727000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">107144000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">14277000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-26513000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="shares" decimals="-3">24913000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">328000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-118000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">3900000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:OperatingExpenses contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">121125000</us-gaap:OperatingExpenses>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-1133000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="shares" decimals="-3">25459000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">-47301000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">5529000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="pure" decimals="4">0.2833</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="shares" decimals="-3">546000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <hae:TransfersFromInventoryToFixedAssets contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">3710000</hae:TransfersFromInventoryToFixedAssets>
  <hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD_per_shares" decimals="2">45.70</hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare>
  <hae:ReversalOfInterestExpenses contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0" unitRef="iso4217_USD" decimals="-3">493000</hae:ReversalOfInterestExpenses>
  <us-gaap:CashFlowHedgeLossReclassifiedToEarnings contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_441306x451457_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-5">4100000</us-gaap:CashFlowHedgeLossReclassifiedToEarnings>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x450145" unitRef="iso4217_USD" decimals="-3">270057000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x472622" unitRef="iso4217_USD" decimals="-3">27230000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478709" unitRef="iso4217_USD" decimals="-3">112431000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478711" unitRef="iso4217_USD" decimals="-3">98671000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478711_456277x478706" unitRef="iso4217_USD" decimals="-3">76063000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478711_456277x478707" unitRef="iso4217_USD" decimals="-3">22608000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712" unitRef="iso4217_USD" decimals="-3">58955000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712_456277x478708" unitRef="iso4217_USD" decimals="-3">32362000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712_456277x478714" unitRef="iso4217_USD" decimals="-3">9355000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712_456277x478715" unitRef="iso4217_USD" decimals="-3">17238000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478713" unitRef="iso4217_USD" decimals="-3">32585000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_450737x445456" unitRef="iso4217_USD" decimals="-3">1400000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0011_STD_182_20101002_0_450737x445456" unitRef="iso4217_USD" decimals="-3">5529000</us-gaap:RestructuringReserveSettledWithCash>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">Q2</dei:DocumentFiscalPeriodFocus>
  <dei:TradingSymbol contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">HAE</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">HAEMONETICS CORP</dei:EntityRegistrantName>
  <dei:AmendmentFlag contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">10-Q</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">2011-10-01</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">0000313143</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">--03-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:GrossProfit contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">178698000</us-gaap:GrossProfit>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">49998000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">4707000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProductWarrantyDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;5.
PRODUCT WARRANTIES&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
generally provide a warranty on parts and labor for one year after
the sale and installation of each device. We also warrant our
disposables products through their use or expiration. We estimate
our potential warranty expense based on our historical warranty
experience, and we periodically assess the adequacy of our warranty
accrual and make adjustments as necessary.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the beginning of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,273&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;903&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
provision&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;603&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;699&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
spending&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(856&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(940&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the end of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,020&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;662&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">130000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-23713000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table presents the effect of our derivative instruments
designated as cash flow hedges and those not designated as hedging
instruments under ASC Topic 815 in our consolidated statement of
income for the six months ended October&amp;#xA0;1, 2011.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="30%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="20%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="20%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount of Loss&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Reclassified&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Recognized&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;from AOCI into&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Excluded from&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;in AOCI&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Earnings&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Effectiveness&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;Derivative Instruments&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Testing (*)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,889&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,896&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Net revenues, COGS, and SG&amp;amp;A&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;167&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Other income&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Non-designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,670&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" nowrap="nowrap" align="left"&gt;Other expense&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px solid" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px solid" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,889&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,896&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,837&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px double" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px double" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left"&gt;
&lt;div style="MARGIN-TOP: 16pt; WIDTH: 18%; FONT-SIZE: 3pt; BORDER-TOP: #000000 1px solid"&gt;
&amp;#xA0;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 3pt; FONT-SIZE: 10pt" align="left"&gt;(*)
&amp;#xA0;&amp;#xA0;We exclude the difference between the spot rate and
hedge forward rate from our effectiveness testing.&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
  <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Revenues
from External Customers:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposable
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Plasma
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;64,408&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;56,514&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Blood center
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Platelet&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;42,195&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;39,746&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Red cell&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,645&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,294&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;53,840&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;51,040&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Hospital
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Surgical&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,206&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;OrthoPAT&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;7,295&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;8,281&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Diagnostics&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5,659&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,647&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;29,160&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;28,939&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposables
revenue&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;147,408&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;136,493&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Software
solutions&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;17,199&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,125&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Equipment &amp;amp;
other&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;14,838&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;14,215&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Net revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;179,445&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;166,833&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposable
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Plasma
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;127,168&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;112,431&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Blood center
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Platelet&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;79,504&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;76,063&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Red cell&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;23,514&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;22,608&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;103,018&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;98,671&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Hospital
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Surgical&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;31,948&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;32,362&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;OrthoPAT&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;15,049&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;17,238&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Diagnostics&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,273&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;9,355&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;58,270&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;58,955&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposables
revenue&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;288,456&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;270,057&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Software
solutions&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;35,359&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;32,585&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Equipment &amp;amp;
other&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;26,199&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27,230&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Net revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;350,014&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;329,872&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">230000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">1332000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:ProductWarrantyAccrualPayments contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">856000</us-gaap:ProductWarrantyAccrualPayments>
  <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-5">2800000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
  <us-gaap:CostOfGoodsSold contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">171316000</us-gaap:CostOfGoodsSold>
  <us-gaap:DerivativesAndFairValueTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;8.
DERIVATIVES AND&amp;#xA0;FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
manufacture, market and sell our products globally. For the six
months ended October&amp;#xA0;1, 2011, approximately 51% of our sales
are generated outside the U.S. generally in local currencies. We
also incur certain manufacturing, marketing and selling costs in
international markets in local currency. Accordingly, our earnings
and cash flows are exposed to market risk from changes in foreign
currency exchange rates relative to the U.S. dollar, our reporting
currency.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We have
a program in place that is designed to mitigate our exposure to
changes in foreign currency exchange rates. That program includes
the use of derivative financial instruments to minimize for a
period of time, the unforeseen impact on our financial results from
changes in foreign exchange rates. We utilize foreign currency
forward contracts to hedge the anticipated cash flows from
transactions denominated in foreign currencies, primarily the
Japanese Yen and the Euro, and to a lesser extent the Swiss Franc,
British Pound Sterling and the Canadian Dollar. This does not
eliminate the volatility of foreign exchange rates, but because we
generally enter into forward contracts one year out, rates are
fixed for a one-year period, thereby facilitating financial
planning and resource allocation.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Designated Foreign Currency Hedge Contracts&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;All of
our designated foreign currency hedge contracts as of
October&amp;#xA0;1, 2011 and April&amp;#xA0;2, 2011 were cash flow hedges
under ASC Topic 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. We record the
effective portion of any change in the fair value of designated
foreign currency hedge contracts in Other Comprehensive Income in
the Statement of Stockholders&amp;#x2019; Equity until the related
third-party transaction occurs. Once the related third-party
transaction occurs, we reclassify the effective portion of any
related gain or loss on the designated foreign currency hedge
contracts to earnings. In the event the hedged forecasted
transaction does not occur, or it becomes probable that it will not
occur, we would reclassify the amount of any gain or loss on the
related cash flow hedge to earnings at that time. We had designated
foreign currency hedge contracts outstanding in the contract amount
of $153.6&amp;#xA0;million as of October&amp;#xA0;1, 2011 and
$154.8&amp;#xA0;million as of April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;During
the six months ended October&amp;#xA0;1, 2011, we recognized net losses
of $2.9&amp;#xA0;million in earnings on our cash flow hedges. For the
six months ended October&amp;#xA0;1, 2011, $2.9&amp;#xA0;million of losses,
net of tax, were recorded in Accumulated Other Comprehensive Income
to recognize the effective portion of the fair value of any
designated foreign currency hedge contracts that are, or previously
were, designated as foreign currency cash flow hedges, as compared
to net losses of $4.1&amp;#xA0;million as of October&amp;#xA0;2, 2010. At
October&amp;#xA0;1, 2011, losses of $2.9&amp;#xA0;million, net of tax, may
be reclassified to earnings within the next twelve months. All
currency cash flow hedges outstanding as of October&amp;#xA0;1, 2011
mature within twelve months.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Non-designated Foreign Currency Contracts&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
manage our exposure to changes in foreign currency on a
consolidated basis to take advantage of offsetting transactions and
balances. We use foreign currency forward contracts as a part of
our strategy to manage exposure related to foreign currency
denominated monetary assets and liabilities. These foreign currency
forward contracts are entered into for periods consistent with
currency transaction exposures, generally one month. They are not
designated as cash flow or fair value hedges under ASC Topic 815.
These forward contracts are marked-to-market with changes in fair
value recorded to earnings. We had non-designated foreign currency
hedge contracts under ASC Topic 815 outstanding in the contract
amount of $48.2&amp;#xA0;million as of October&amp;#xA0;1, 2011 and $45.9
million as of April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;&lt;u&gt;Fair
Value of Derivative Instruments&lt;/u&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table presents the effect of our derivative instruments
designated as cash flow hedges and those not designated as hedging
instruments under ASC Topic 815 in our consolidated statement of
income for the six months ended October&amp;#xA0;1, 2011.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="30%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="20%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="20%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount of Loss&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Reclassified&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Recognized&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;from AOCI into&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Excluded from&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;in AOCI&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Earnings&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Effectiveness&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;Derivative Instruments&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Testing (*)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,889&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,896&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Net revenues, COGS, and SG&amp;amp;A&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;167&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Other income&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Non-designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,670&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" nowrap="nowrap" align="left"&gt;Other expense&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px solid" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px solid" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,889&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,896&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,837&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px double" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 0px double" valign="top" colspan="2" nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left"&gt;
&lt;div style="MARGIN-TOP: 16pt; WIDTH: 18%; FONT-SIZE: 3pt; BORDER-TOP: #000000 1px solid"&gt;
&amp;#xA0;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 3pt; FONT-SIZE: 10pt" align="left"&gt;(*)
&amp;#xA0;&amp;#xA0;We exclude the difference between the spot rate and
hedge forward rate from our effectiveness testing.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We did
not have fair value hedges or net investment hedges outstanding as
of October&amp;#xA0;1, 2011 or April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;ASC
Topic 815 requires all derivative instruments to be recognized at
their fair values as either assets or liabilities on the balance
sheet. We determine the fair value of our derivative instruments
using the framework prescribed by ASC Topic 820, &lt;i&gt;Fair Value
Measurements and Disclosures&lt;/i&gt;, by considering the estimated
amount we would receive or pay to sell or transfer these
instruments at the reporting date and by taking into account
current interest rates, currency exchange rates, the
creditworthiness of the counterparty for assets, and our
creditworthiness for liabilities. In certain instances, we may
utilize financial models to measure fair value. Generally, we use
inputs that include quoted prices for similar assets or liabilities
in active markets; quoted prices for identical or similar assets or
liabilities in markets that are not active; other observable inputs
for the asset or liability; and inputs derived principally from, or
corroborated by, observable market data by correlation or other
means. As of October&amp;#xA0;1, 2011, we have classified our
derivative assets and liabilities within Level 2 of the fair value
hierarchy prescribed by ASC Topic 815, as discussed below, because
these observable inputs are available for substantially the full
term of our derivative instruments.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following tables present the fair value of our derivative
instruments as they appear in our consolidated balance sheets as of
October&amp;#xA0;1, 2011 by type of contract and whether it is a
qualifying hedge under ASC Topic 815.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="30%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="20%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="6%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="6%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center"&gt;Balance Sheet&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Assets:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Other current assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Liabilities:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Other current liabilities&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,174&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,174&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;&lt;u&gt;Other
Fair Value Measurements&lt;/u&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;ASC
Topic 820, &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, defines
fair value, establishes a framework for measuring fair value in
accordance with U.S. GAAP, and expands disclosures about fair value
measurements. ASC Topic 820 does not require any new fair value
measurements; rather, it applies to other accounting pronouncements
that require or permit fair value measurements. In accordance with
ASC Topic 820, for the quarter and the six months ended
October&amp;#xA0;1, 2011, we applied the requirements under ASC Topic
820 to our non-financial assets and non-financial liabilities. As
we did not have an impairment of any non-financial assets or
non-financial liabilities, there was no disclosure required
relating to our non-financial assets or non-financial
liabilities.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;On a
recurring basis, we measure certain financial assets and financial
liabilities at fair value, including our money market funds,
foreign currency hedge contracts, and contingent consideration. ASC
Topic 820 defines fair value as the price that would be received to
sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. As
such, fair value is a market-based measurement that should be
determined based on assumptions that market participants would use
in pricing an asset or liability. We base fair value upon quoted
market prices, where available. Where quoted market prices or other
observable inputs are not available, we apply valuation techniques
to estimate fair value.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;ASC
Topic 820 establishes a three-level valuation hierarchy for
disclosure of fair value measurements. The categorization of assets
and liabilities within the valuation hierarchy is based upon the
lowest level of input that is significant to the measurement of
fair value. The three levels of the hierarchy are defined as
follows:&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr style="BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; FONT-SIZE: 10pt" valign="top"&gt;
&lt;td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%" nowrap="nowrap" align="left"&gt;&lt;b&gt;&amp;#x2022;&lt;/b&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;Level 1 &amp;#x2014; Inputs to the valuation methodology are quoted
market prices for identical assets or liabilities.&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="FONT-SIZE: 6pt"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; FONT-SIZE: 10pt" valign="top"&gt;
&lt;td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%" nowrap="nowrap" align="left"&gt;&lt;b&gt;&amp;#x2022;&lt;/b&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;Level 2 &amp;#x2014; Inputs to the valuation methodology are other
observable inputs, including quoted market prices for similar
assets or liabilities and market-corroborated inputs.&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="FONT-SIZE: 6pt"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; FONT-SIZE: 10pt" valign="top"&gt;
&lt;td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%" nowrap="nowrap" align="left"&gt;&lt;b&gt;&amp;#x2022;&lt;/b&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;Level 3 &amp;#x2014; Inputs to the valuation methodology are
unobservable inputs based on management&amp;#x2019;s best estimate of
inputs market participants would use in pricing the asset or
liability at the measurement date, including assumptions about
risk.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Our
money market funds carried at fair value are classified within
Level 1 of the fair value hierarchy because they are valued using
quoted market prices.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
recognize all derivative financial instruments in our consolidated
financial statements at fair value in accordance with ASC Topic
815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. We determine the fair value of
these instruments using the framework prescribed by ASC Topic 820
by considering the estimated amount we would receive or pay to
terminate these agreements at the reporting date and by taking into
account current spot rates, the creditworthiness of the
counterparty for assets, and our creditworthiness for liabilities.
We have classified our foreign currency hedge contracts within
Level 2 of the fair value hierarchy because these observable inputs
are available for substantially the full term of our derivative
instruments. The fair value of our foreign currency hedge contracts
is the estimated amount that the Company would receive or pay upon
liquidation of the contracts, taking into account the change in
currency exchange rates.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;i&gt;Fair
Value Measured on a Recurring Basis&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Financial assets and financial liabilities measured at fair value
on a recurring basis consist of the following as of October&amp;#xA0;1,
2011:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="52%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Quoted Market&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Other&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Prices for&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Observable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Unobservable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Identical
Assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 1)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 2)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 3)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Total&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Assets&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Money market
funds&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;143,035&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;143,035&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Foreign currency
hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;143,035&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;144,576&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Liabilities&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Foreign currency
hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Release of Neoteric contingent consideration&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Under
ASC Topic 805, &lt;i&gt;Business Combinations&lt;/i&gt;, we established a
liability for payments that we might make in the future to former
shareholders of Neoteric that are tied to the performance of the
Blood Track business for the first three years post acquisition,
beginning with fiscal year 2010. We have reviewed the expected
performance versus the necessary thresholds of performance for the
former shareholders to receive additional performance payments and
we recorded an adjustment to the fair value of the contingent
consideration as contingent consideration income of
$1.6&amp;#xA0;million in the accompanying consolidated statements of
income, reversing the remaining liability, as the expected
performance thresholds will not be achieved.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;In
September&amp;#xA0;2011, we entered into an agreement to release the
Company from the contingent consideration due to the former
shareholders of Neoteric. Under the terms of the agreement, the
former shareholders of Neoteric received $0.7&amp;#xA0;million in
exchange for releasing the Company from any future claims for
contingent consideration. The Company paid the $0.7&amp;#xA0;million
settlement amount during September&amp;#xA0;2011 and has recorded the
associated expense in the selling, general and administrative line
item in the accompanying consolidated statements of income.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Other Fair Value Disclosures&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The fair
value of our real estate mortgage obligation was $3.7&amp;#xA0;million
and $4.1&amp;#xA0;million at October 1, 2011 and April&amp;#xA0;2, 2011,
respectively.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-742000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;b&gt;10&lt;/b&gt;&lt;font style="FONT-VARIANT: small-caps"&gt;&lt;b&gt;.&lt;/b&gt;&lt;/font&gt;
&lt;font style="FONT-VARIANT: small-caps"&gt;&lt;b&gt;C&lt;/b&gt;&lt;/font&gt;&lt;b&gt;OMMITMENTS
AND CONTINGENCIES&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We are
presently engaged in various legal actions, and although ultimate
liability cannot be determined at the present time, we believe,
based on consultation with counsel, that any such liability will
not materially affect our consolidated financial position or our
results of operations.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;During
the first quarter of fiscal 2012, we received customer complaints
in Europe regarding a quality issue with our High Separation Core
Bowl&amp;#xA0;(&amp;#x201C;HS Core&amp;#x201D;), a plasma disposable product used
primarily to collect plasma for transfusion. Certain of these
customers have also made claims regarding financial losses alleged
to have been incurred as a result of this matter. Total aggregate
claims submitted to date by customers relating to this issue are
approximately $8.5&amp;#xA0;million. We do not expect any additional
material claims from our customers. We are in the process of
evaluating the submitted claims and continue to work with affected
customers to minimize disruption to their operations and ultimately
determine the validity and resolution of the submitted claims.
Although this process is not completed, we have determined that it
is probable that we will compensate certain affected customers in
order to resolve their claims. We believe our ultimate liability
will be less than the total claims submitted to date. Our current
best estimate of the liability associated with this matter is $2.4
million, and accordingly we have recorded this amount as an expense
within selling, general and administrative expenses as of
October&amp;#xA0;1, 2011. We cannot determine currently whether a
liability greater than $2.4&amp;#xA0;million will ultimately be
incurred. We are also in the process of determining the extent to
which claims may be recoverable under the Company&amp;#x2019;s insurance
policies. We do not currently believe that liabilities related to
this matter will materially affect our consolidated financial
position and liquidity.&lt;/div&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="font-family: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;
&lt;b&gt;11&lt;/b&gt;&lt;font style="FONT-variant: SMALL-CAPS"&gt;&lt;b&gt;.&lt;/b&gt;&lt;/font&gt;
&lt;font style="FONT-variant: SMALL-CAPS"&gt;&lt;b&gt;SEGMENT
INFORMATION&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;
&lt;i&gt;Segment Definition Criteria&lt;/i&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;We
manage our business on the basis of one operating segment: the
design, manufacture, and marketing of blood management solutions.
Our chief operating decision-maker uses consolidated results to
make operating and strategic decisions. Manufacturing processes, as
well as the regulatory environment in which we operate, are largely
the same for all product lines.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;
&lt;i&gt;Enterprise Wide Disclosures about Product and Services&lt;/i&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;We have
four global product families: plasma, blood center, hospital, and
software solutions.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Our
products include equipment devices and the related disposables used
with these devices. Disposables include the plasma, blood center,
and hospital product families. Plasma consists of the disposables
used to perform apheresis for the separation of whole blood
components and subsequent collection of plasma to be used as a raw
material for biologically derived pharmaceuticals (also known as
source plasma). Blood center consists of disposables which separate
whole blood for the subsequent collection of platelets, plasma, red
cells, or a combination of these components for transfusion to
patients. Hospital consists of surgical disposables (principally
the Cell Saver&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; and Cell
Saver Elite &lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; autologous
blood recovery systems targeted to procedures that involve rapid,
high volume blood loss such as cardiovascular surgeries and the
cardioPAT&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt;
cardiovascular perioperative autotransfusion system designed to
remain with the patient following surgery to recover blood and the
patient&amp;#x2019;s red cells to prepare them for reinfusion), the
OrthoPAT&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; orthopedic
perioperative autotransfusion system designed to operate both
during and after surgery to recover and wash the patient&amp;#x2019;s
red cells to prepare them for reinfusion, and diagnostics products
(principally the TEG&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt;
Thrombelastograph&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; hemostasis
analyzer used to help assess a surgical patient&amp;#x2019;s hemostasis
(blood clotting ability) during and after surgery).&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;
Disposables (single-use sterile kits used in our devices for
collection or salvage of blood products) are marketed in our
plasma, blood center, and hospital product businesses. Plasma
disposables are used with our PCS&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt;2 devices to
perform apheresis for the collection of plasma to be used as a raw
material for biologically derived pharmaceuticals (also known as
source plasma). Blood center disposables are used with our MCS+
device to collect one or more blood components (principally
platelets but also red cells and plasma) for transfusion to
patients. The Hospital business consists of disposables used with
our Cell Saver&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; and
cardioPAT&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; devices to
recover red cells from blood lost in a surgical procedure so that
these may be made available for reinfusion to the patient
(&amp;#x201C;autotransfusion&amp;#x201D;). OrthoPAT&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; disposables
are used for autotransfusion during and immediately following
orthopedic surgeries. Diagnostics products principally reflect
sales of diagnostic reagents and the TEG&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt;
Thrombelastograph&lt;sup style="FONT-size: 85%; vertical-align: text-top"&gt;&amp;#xAE;&lt;/sup&gt; hemostasis
analyzer which profiles a patient&amp;#x2019;s blood clotting
characteristics.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Software
solutions include information technology platforms that assist
blood centers, plasma centers, and hospitals to more effectively
manage regulatory compliance and operational efficiency.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="font-family: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Revenues
from External Customers:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposable
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Plasma
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;64,408&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;56,514&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Blood center
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Platelet&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;42,195&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;39,746&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Red cell&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,645&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,294&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;53,840&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;51,040&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Hospital
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Surgical&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,206&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;OrthoPAT&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;7,295&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;8,281&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:60px; text-indent:-15px"&gt;Diagnostics&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5,659&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,647&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;29,160&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;28,939&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposables
revenue&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;147,408&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;136,493&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Software
solutions&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;17,199&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,125&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Equipment &amp;amp;
other&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;14,838&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;14,215&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Net revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;179,445&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;166,833&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposable
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Plasma
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;127,168&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;112,431&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Blood center
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Platelet&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;79,504&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;76,063&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Red cell&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;23,514&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;22,608&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;103,018&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;98,671&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;Hospital
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Surgical&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;31,948&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;32,362&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;OrthoPAT&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;15,049&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;17,238&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:45px; text-indent:-15px"&gt;Diagnostics&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,273&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;9,355&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;58,270&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;58,955&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Disposables
revenue&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;288,456&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;270,057&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Software
solutions&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;35,359&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;32,585&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Equipment &amp;amp;
other&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;26,199&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27,230&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Net revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;350,014&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;329,872&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:30px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="pure" decimals="4">0.0160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">52539000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="shares" decimals="INF">41067</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">30072000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;3.
EARNINGS PER SHARE (&amp;#x201C;EPS&amp;#x201D;)&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table provides a reconciliation of the numerators and
denominators of the basic and diluted earnings per share
computations. Basic EPS is computed by dividing net income by
weighted average shares outstanding. Diluted EPS includes the
effect of potentially dilutive common shares.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands,
except per share amounts)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Basic
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;13,880&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;21,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Weighted average
shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,418&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,686&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic income per
share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.55&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.86&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Diluted
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;13,880&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;21,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,418&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,686&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net effect of
common stock equivalents&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;425&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;542&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,843&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,228&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted income
per share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.54&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.85&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands,
except per share amounts)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Basic
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,828&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;39,257&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Weighted average
shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,575&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,913&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic income per
share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.21&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.58&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Diluted
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,828&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;39,257&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,575&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,913&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net effect of
common stock equivalents&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;454&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;546&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;26,029&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,459&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted income
per share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.18&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.54&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Weighted
average shares outstanding, assuming dilution, excludes the impact
of 0.4&amp;#xA0;million and 1.1&amp;#xA0;million stock options for the
second quarter of fiscal year 2012 and 2011, respectively, 0.4
million and 0.8&amp;#xA0;million stock options for the first six months
of fiscal year 2012 and 2011, respectively, because these
securities were anti-dilutive during the noted periods.&lt;/div&gt;
&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">1847000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">42705000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">4701000</us-gaap:ShareBasedCompensation>
  <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;A
summary of the components of other comprehensive income is as
follows:&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;13,880&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;21,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
comprehensive income:&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Net change in
minimum pension liability, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Foreign currency
translation&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(2,447&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;7,481&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Unrealized loss
on cash flow hedges, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(1,566&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(4,519&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;
Reclassifications into earnings of cash flow hedge losses, net of
tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,259&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;149&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
comprehensive income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;11,126&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;24,476&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,828&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;39,257&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
comprehensive income:&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Net change in
minimum pension liability, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(21&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(22&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Foreign currency
translation&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(742&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;3,234&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Unrealized loss
on cash flow hedges, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(2,889&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(4,069&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;
Reclassifications into earnings of cash flow hedge losses, net of
tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,896&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;118&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
comprehensive income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,072&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;38,518&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
  <us-gaap:BasisOfAccounting contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;b&gt;1.
BASIS OF PRESENTATION&lt;/b&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Our
accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting
principles (&amp;#x201C;GAAP&amp;#x201D;) in the United States for interim
financial information and with the instructions to Form 10-Q and
Article&amp;#xA0;10 of Regulation&amp;#xA0;S-X. Accordingly, they do not
include all of the information and footnotes required by GAAP for
complete financial statements. In the opinion of our management,
all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included.
All significant intercompany transactions have been eliminated.
Certain reclassifications were made to prior year balances to
conform to the presentation of the financial statements for the six
months ended October&amp;#xA0;1, 2011. Operating results for the six
month period ended October&amp;#xA0;1, 2011 are not necessarily
indicative of the results that may be expected for the full fiscal
year ending March 31, 2012, or any other interim period. These
unaudited consolidated financial statements should be read in
conjunction with our audited consolidated financial statements and
footnotes included in our annual report on Form 10-K for the fiscal
year ended April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
Company considers events or transactions that occur after the
balance sheet date but prior to the issuance of the financial
statements to provide additional evidence relative to certain
estimates or to identify matters that require additional
disclosure. Subsequent events have been evaluated, and these
financial statements reflect those material items that arose after
the balance sheet date but prior to the issuance of the financial
statements that would be considered recognized subsequent events.
There were no material recognized subsequent events recorded in the
October&amp;#xA0;1, 2011 consolidated financial statements.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Our
fiscal year ends on the Saturday closest to the last day of March.
Fiscal years 2012 and 2011 include 52&amp;#xA0;weeks with all four
quarters each having 13&amp;#xA0;weeks.&lt;/div&gt;
&lt;/div&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2">1.18</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table provides a reconciliation of the numerators and
denominators of the basic and diluted earnings per share
computations. Basic EPS is computed by dividing net income by
weighted average shares outstanding. Diluted EPS includes the
effect of potentially dilutive common shares.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands,
except per share amounts)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Basic
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;13,880&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;21,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Weighted average
shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,418&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,686&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic income per
share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.55&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.86&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Diluted
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;13,880&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;21,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,418&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,686&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net effect of
common stock equivalents&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;425&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;542&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,843&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,228&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted income
per share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.54&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.85&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands,
except per share amounts)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Basic
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,828&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;39,257&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Weighted average
shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,575&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,913&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic income per
share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.21&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.58&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Diluted
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,828&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;39,257&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,575&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;24,913&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net effect of
common stock equivalents&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;454&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;546&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;26,029&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,459&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted income
per share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.18&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1.54&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-2059000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">2288000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-278000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-2889000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
following summarizes the restructuring activity for the six months
ended October&amp;#xA0;1, 2011 and October&amp;#xA0;2, 2010,
respectively:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="52%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000"&gt;Six Months Ended October 1,
2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,782&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,528&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,327&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,983&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Facility-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;889&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;480&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(713&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;656&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,671&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,008&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(3,040&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,639&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="52%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000"&gt;Six Months Ended October 2,
2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;April 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,400&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(5,529&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;5,632&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,400&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(5,529&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;5,632&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
  <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following tables present the fair value of our derivative
instruments as they appear in our consolidated balance sheets as of
October&amp;#xA0;1, 2011 by type of contract and whether it is a
qualifying hedge under ASC Topic 815.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="30%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="20%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="6%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="6%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center"&gt;Balance Sheet&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Assets:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Other current assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Liabilities:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;Other current liabilities&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,174&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,174&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">634000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;6.
COMPREHENSIVE INCOME&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Comprehensive income is the total of net income and all other
non-owner changes in stockholders&amp;#x2019; equity. Other non-owner
changes are primarily foreign currency translation, the change in
our net minimum pension liability, and the changes in fair value of
the effective portion of our outstanding cash flow hedge
contracts.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;A
summary of the components of other comprehensive income is as
follows:&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;13,880&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;21,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
comprehensive income:&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Net change in
minimum pension liability, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Foreign currency
translation&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(2,447&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;7,481&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Unrealized loss
on cash flow hedges, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(1,566&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(4,519&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;
Reclassifications into earnings of cash flow hedge losses, net of
tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,259&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;149&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
comprehensive income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;11,126&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;24,476&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,828&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;39,257&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
comprehensive income:&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Net change in
minimum pension liability, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(21&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(22&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Foreign currency
translation&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(742&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;3,234&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Unrealized loss
on cash flow hedges, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(2,889&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(4,069&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;
Reclassifications into earnings of cash flow hedge losses, net of
tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,896&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;118&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
comprehensive income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,072&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;38,518&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2">18.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">30828000</us-gaap:NetIncomeLoss>
  <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
estimate our potential warranty expense based on our historical
warranty experience, and we periodically assess the adequacy of our
warranty accrual and make adjustments as necessary.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the beginning of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,273&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;903&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
provision&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;603&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;699&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
spending&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(856&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(940&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the end of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,020&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;662&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">3008000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">18959000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">333000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">1580000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-5">4700000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="shares" decimals="-5">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">603000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">23843000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2">1.21</us-gaap:EarningsPerShareBasic>
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;
&lt;b&gt;12&lt;/b&gt;&lt;font style="FONT-variant: SMALL-CAPS"&gt;&lt;b&gt;.&lt;/b&gt;&lt;/font&gt;
&lt;font style="FONT-variant: SMALL-CAPS"&gt;&lt;b&gt;REORGANIZATION&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During
the six months ended October&amp;#xA0;1, 2011, the Company&amp;#x2019;s
restructuring activities primarily consist of reorganization within
our research and development, manufacturing and software
operations. Employee-related costs primarily consist of employee
severance and benefits. Facility-related costs primarily consist of
charges associated with closing facilities, related lease
obligations, and other related costs.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;For the
six months ended October&amp;#xA0;1, 2011, the Company incurred
$3.0&amp;#xA0;million of restructuring charges. Restructuring expenses
have been primarily included as a component of selling, general and
administrative expense in the accompanying statements of income. We
anticipate that the Company will incur approximately $5 to
$6&amp;#xA0;million in additional restructuring charges related to
these initiatives over the remaining six months of fiscal year
2012.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
following summarizes the restructuring activity for the six months
ended October&amp;#xA0;1, 2011 and October&amp;#xA0;2, 2010,
respectively:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="52%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000"&gt;Six Months Ended October 1,
2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,782&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,528&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,327&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,983&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Facility-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;889&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;480&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(713&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;656&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,671&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,008&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(3,040&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,639&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="52%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000"&gt;Six Months Ended October 2,
2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;April 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,400&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(5,529&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;5,632&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,400&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(5,529&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;5,632&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">24619000</us-gaap:DepreciationAndAmortization>
  <us-gaap:TaxBenefitFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">952000</us-gaap:TaxBenefitFromStockOptionsExercised>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">42475000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestPaidNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">220000</us-gaap:InterestPaidNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">350014000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">1992000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:InventoryDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;b&gt;7.
INVENTORIES&lt;/b&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;
Inventories are stated at the lower of cost or market and include
the cost of material, labor and manufacturing overhead. Cost is
determined on the first-in, first-out method.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Raw
materials&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;35,333&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;26,404&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;
Work-in-process&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,301&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,352&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Finished
goods&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;61,810&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;53,631&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;101,444&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;84,387&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">21000</us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
assumptions utilized for estimating the fair value of option grants
during the periods presented are as follows:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Stock Options
Black-Scholes assumptions (weighted average):&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Volatility&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27.42&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;28.33&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Expected life
(years)&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4.9&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4.9&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Risk-free
interest rate&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1.60&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2.43&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Dividend
yield&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-5">1300000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
  <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-12283000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="Year" decimals="1">4.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">1267000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">118844000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">11877000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;
Inventories are stated at the lower of cost or market and include
the cost of material, labor and manufacturing overhead. Cost is
determined on the first-in, first-out method.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" colspan="6"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Raw
materials&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;35,333&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;26,404&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;
Work-in-process&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,301&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,352&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom" style="background: #cceeff"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;Finished
goods&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;61,810&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;53,631&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;101,444&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;84,387&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font-size: 1px"&gt;
&lt;td&gt;
&lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-13286000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="shares" decimals="-3">25575000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-359000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;b&gt;9.
INCOME TAXES&lt;/b&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
Company&amp;#x2019;s reported tax rate was 27.0% and 27.8% for the three
and six month periods ended October&amp;#xA0;1, 2011, respectively. Our
reported tax rate is lower than the federal statutory tax rate in
both periods reported primarily due to lower foreign tax rates,
including tax benefits associated with our Swiss operations.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;We
conduct business globally and, as a result, file consolidated
federal, consolidated and separate state and foreign income tax
returns in multiple jurisdictions. In the normal course of
business, we are subject to examination by taxing authorities
throughout the world in jurisdictions including the U.S., Japan,
Germany, France, the United Kingdom, and Switzerland. With few
exceptions, we are no longer subject to U.S. federal, state and
local, or foreign income tax examinations for years before
2007.&lt;/div&gt;
&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-2896000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">15390000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:OperatingExpenses contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">136223000</us-gaap:OperatingExpenses>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;4.
STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Stock-based compensation expense of $4.7&amp;#xA0;million and
$4.1&amp;#xA0;million was recognized for the six months ended
October&amp;#xA0;1, 2011 and October&amp;#xA0;2, 2010, respectively. The
related income tax benefit recognized was $1.3&amp;#xA0;million for the
six months ended October&amp;#xA0;1, 2011 and October&amp;#xA0;2,
2010.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
weighted average fair value for our options granted in the first
six months of fiscal year 2012 and 2011 was $18.27 and $16.89,
respectively. The assumptions utilized for estimating the fair
value of option grants during the periods presented are as
follows:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Six Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 1, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;October 2, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Stock Options
Black-Scholes assumptions (weighted average):&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Volatility&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27.42&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;28.33&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Expected life
(years)&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4.9&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4.9&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Risk-free
interest rate&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1.60&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2.43&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Dividend
yield&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;During
the six months ended October&amp;#xA0;1, 2011 and October&amp;#xA0;2, 2010,
there were 41,067 and 35,992 shares, respectively, purchased under
the ESPP. They were purchased at $46.80 and $45.70 per share,
respectively, under the ESPP.&lt;/div&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="pure" decimals="3">0.278</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-1080000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;
&lt;b&gt;13&lt;/b&gt;&lt;font style="FONT-variant: SMALL-CAPS"&gt;&lt;b&gt;.&lt;/b&gt;&lt;/font&gt;
&lt;font style="FONT-variant: SMALL-CAPS"&gt;&lt;b&gt;CAPITALIZATION OF
SOFTWARE DEVELOPMENT COSTS&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;For
costs incurred related to the development of software to be sold,
leased, or otherwise marketed, the Company applies the provisions
of ASC Topic 985-20, &lt;i&gt;Software&lt;/i&gt;, which specifies that costs
incurred internally in researching and developing a computer
software product should be charged to expense until technological
feasibility has been established for the product. Once
technological feasibility is established, all software costs should
be capitalized until the product is available for general release
to customers.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
Company capitalized $2.8&amp;#xA0;million and $3.4&amp;#xA0;million in
software development costs for ongoing initiatives during the six
month periods ended October&amp;#xA0;1, 2011 and October&amp;#xA0;2, 2010,
respectively. At October&amp;#xA0;1, 2011 and April&amp;#xA0;2, 2011, we
have a total of $12.2&amp;#xA0;million and $13.4&amp;#xA0;million,
respectively, of costs capitalized related to in process software
development initiatives. The costs capitalized for each project are
included in intangible assets in the consolidated financial
statements.&lt;/div&gt;
&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="shares" decimals="-3">26029000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">-41753000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Financial assets and financial liabilities measured at fair value
on a recurring basis consist of the following as of October&amp;#xA0;1,
2011:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="52%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Quoted Market&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Other&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Prices for&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Observable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Unobservable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Identical
Assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 1)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 2)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 3)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Total&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Assets&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Money market
funds&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;143,035&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;143,035&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Foreign currency
hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;143,035&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,541&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;144,576&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Liabilities&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Foreign currency
hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,185&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;


&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">3040000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="pure" decimals="4">0.2742</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="shares" decimals="-3">454000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <hae:TransfersFromInventoryToFixedAssets contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">6292000</hae:TransfersFromInventoryToFixedAssets>
  <hae:NewAccountingPronouncementsAndChangesInAccountingPrinciplesDisclosureTextBlock contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0">&lt;div&gt;
&lt;div style="font-family: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;b&gt;2.
RECENT ACCOUNTING PRONOUNCEMENTS&lt;/b&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
May&amp;#xA0;2011, the FASB issued Accounting Standards Update
No.&amp;#xA0;2011-04, &lt;i&gt;Fair Value Measurement (Topic 820): Amendments
to Achieve Common Fair Value Measurement and Disclosure
Requirements in U.S. GAAP and IFRSs.&lt;/i&gt; Update No.&amp;#xA0;2011-04
updates the accounting guidance related to fair value measurements
that results in a consistent definition of fair value and common
requirements for measurement of and disclosure about fair value
between U.S. GAAP and International Financial Reporting Standards
(IFRS). The updated guidance is effective for interim and annual
periods beginning after December&amp;#xA0;15, 2011. Early application
is not permitted. We are currently evaluating the potential impact
of Update No. 2011-04 on our consolidated financial statements.
This statement is effective for our fourth quarter of fiscal year
2012.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
June&amp;#xA0;2011, the FASB issued Accounting Standards Update
No.&amp;#xA0;2011-05, &lt;i&gt;Comprehensive Income (Topic 220): Presentation
of Comprehensive Income&lt;/i&gt;. Update No.&amp;#xA0;2011-05 updates the
disclosure requirements for comprehensive income to include total
comprehensive income, the components of net income, and the
components of other comprehensive income either in a single
continuous statement of comprehensive income or in two separate but
consecutive statements. The updated guidance does not affect how
earnings per share is calculated or presented. The updated guidance
is effective for fiscal years, and interim periods within those
years, beginning after December&amp;#xA0;15, 2011, and should be
applied retrospectively. Early adoption is permitted and amendments
do not require any transition disclosures. This statement is
effective in our first quarter of fiscal year 2013.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
September&amp;#xA0;2011, the FASB issued Accounting Standards Update
No.&amp;#xA0;2011-08, &lt;i&gt;Intangibles &amp;#x2014; Goodwill and Other (Topic
350)&lt;/i&gt;. ASU 2011-08 allows entities to first assess qualitatively
whether it is necessary to perform the two-step goodwill impairment
test. If an entity believes, as a result of its qualitative
assessment, that it is more likely than not that the fair value of
a reporting unit is less than its carrying amount, the quantitative
two-step goodwill impairment test is required. An entity has the
unconditional option to bypass the qualitative assessment and
proceed directly to performing the first step of the goodwill
impairment test. The Company anticipates that the adoption of this
standard will not have a material impact on its consolidated
financial statements and footnote disclosures.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="font-family: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;
&lt;b&gt;&lt;i&gt;Standards Implemented&lt;/i&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
October&amp;#xA0;2009, the FASB issued Accounting Standards Update
No.&amp;#xA0;2009-13, &lt;i&gt;Revenue Recognition (Topic 605):
Multiple-Deliverable Revenue Arrangements&lt;/i&gt;, and Accounting
Standards Update No. 2009-14, &lt;i&gt;Software (Topic 985): Certain
Revenue Arrangements That Include Software&lt;/i&gt; (the
&amp;#x201C;Updates&amp;#x201D;). The Updates provide guidance on
arrangements that include software elements, including tangible
products that have software components that are essential to the
functionality of the tangible product and will no longer be within
the scope of the software revenue recognition guidance, and
software-enabled products that will now be subject to other
relevant revenue recognition guidance. The Updates also provide
authoritative guidance on revenue arrangements with multiple
deliverables that are outside the scope of the software revenue
recognition guidance. Under the new guidance, when vendor specific
objective evidence or third party evidence of fair value for
deliverables in an arrangement cannot be determined, a best
estimate of the selling price is required to allocate arrangement
consideration using the relative selling price method. The Updates
also include new disclosure requirements on how the application of
the relative selling price method affects the timing and amount of
revenue recognition. On April&amp;#xA0;3, 2011, the Company adopted
this guidance, which did not have a material impact on our
financial position or results of operations.&lt;/div&gt;
&lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
December&amp;#xA0;2010, the FASB issued Accounting Standards Update
No.&amp;#xA0;2010-29, &lt;i&gt;Business Combinations (Topic 805): Disclosure
of Supplementary Pro Forma Information for Business
Combinations&lt;/i&gt;. Update No.&amp;#xA0;2010-29 clarifies paragraph
805-10-50-2(h) to require public entities that enter into business
combinations that are material on an individual or aggregate basis
to disclose pro forma information for such business combinations
that occurred in the current reporting period, including pro forma
revenue and earnings of the combined entity as though the
acquisition date had been as of the beginning of the comparable
prior annual reporting period only. We did not complete any
material business acquisitions during the six months ended
October&amp;#xA0;1, 2011 thus the disclosure requirements were not
applicable for the period.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</hae:NewAccountingPronouncementsAndChangesInAccountingPrinciplesDisclosureTextBlock>
  <hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2">46.80</hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare>
  <hae:ReversalOfInterestExpenses contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0" unitRef="iso4217_USD" decimals="-3">574000</hae:ReversalOfInterestExpenses>
  <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_446729x454321_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-3" id="fnid_30437438_1001_1">167000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_446729x478703_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-3">-2889000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_446729x478703_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-3">2896000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:CashFlowHedgeLossReclassifiedToEarnings contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-5">2900000</us-gaap:CashFlowHedgeLossReclassifiedToEarnings>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x450145" unitRef="iso4217_USD" decimals="-3">288456000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x472622" unitRef="iso4217_USD" decimals="-3">26199000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478709" unitRef="iso4217_USD" decimals="-3">127168000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478711" unitRef="iso4217_USD" decimals="-3">103018000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478711_456277x478706" unitRef="iso4217_USD" decimals="-3">79504000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478711_456277x478707" unitRef="iso4217_USD" decimals="-3">23514000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712" unitRef="iso4217_USD" decimals="-3">58270000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712_456277x478708" unitRef="iso4217_USD" decimals="-3">31948000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712_456277x478714" unitRef="iso4217_USD" decimals="-3">11273000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712_456277x478715" unitRef="iso4217_USD" decimals="-3">15049000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478713" unitRef="iso4217_USD" decimals="-3">35359000</us-gaap:SalesRevenueGoodsNet>
  <hae:PercentageOfNetSales contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_446310x453298" unitRef="pure" decimals="2">0.51</hae:PercentageOfNetSales>
  <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_446729x454493_449485x445999_451532x449846" unitRef="iso4217_USD" decimals="-3" id="fnid_30437438_1002_1">1670000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_449485x455587" unitRef="iso4217_USD" decimals="-5">2900000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-5">2900000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_450737x445456" unitRef="iso4217_USD" decimals="-3">2528000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_450737x445456" unitRef="iso4217_USD" decimals="-3">2327000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_450737x447194" unitRef="iso4217_USD" decimals="-3">480000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_450737x447194" unitRef="iso4217_USD" decimals="-3">713000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_451532x449846" unitRef="iso4217_USD" decimals="-3" id="fnid_30437438_1003_1">1837000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_451532x449846" unitRef="iso4217_USD" decimals="-3">-2889000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_451532x449846" unitRef="iso4217_USD" decimals="-3">2896000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:RestructuringAndRelatedCostExpectedCost contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_454814x452760" unitRef="iso4217_USD" decimals="-6">5000000</us-gaap:RestructuringAndRelatedCostExpectedCost>
  <us-gaap:RestructuringAndRelatedCostExpectedCost contextRef="eol_PE5753----1110-Q0011_STD_182_20111001_0_454814x454410" unitRef="iso4217_USD" decimals="-6">6000000</us-gaap:RestructuringAndRelatedCostExpectedCost>
  <hae:ContingentConsiderationPaid contextRef="eol_PE5753----1110-Q0011_STD_30_20110930_0" unitRef="iso4217_USD" decimals="-5">700000</hae:ContingentConsiderationPaid>
  <us-gaap:GrossProfit contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">87755000</us-gaap:GrossProfit>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">254000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:CostOfGoodsSold contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">79078000</us-gaap:CostOfGoodsSold>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">7481000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">24476000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">29159000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD_per_shares" decimals="2">0.85</us-gaap:EarningsPerShareDiluted>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">-4519000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">21338000</us-gaap:NetIncomeLoss>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">7954000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">1894000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="shares" decimals="-5">1100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD_per_shares" decimals="2">0.86</us-gaap:EarningsPerShareBasic>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">28905000</us-gaap:OperatingIncomeLoss>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">166833000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">-27000</us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">52790000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">7821000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="shares" decimals="-3">24686000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">-149000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:OperatingExpenses contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="iso4217_USD" decimals="-3">58850000</us-gaap:OperatingExpenses>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="shares" decimals="-3">25228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0" unitRef="shares" decimals="-3">542000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x450145" unitRef="iso4217_USD" decimals="-3">136493000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x472622" unitRef="iso4217_USD" decimals="-3">14215000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478709" unitRef="iso4217_USD" decimals="-3">56514000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478711" unitRef="iso4217_USD" decimals="-3">51040000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478711_456277x478706" unitRef="iso4217_USD" decimals="-3">39746000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478711_456277x478707" unitRef="iso4217_USD" decimals="-3">11294000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712" unitRef="iso4217_USD" decimals="-3">28939000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712_456277x478708" unitRef="iso4217_USD" decimals="-3">16011000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712_456277x478714" unitRef="iso4217_USD" decimals="-3">4647000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712_456277x478715" unitRef="iso4217_USD" decimals="-3">8281000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478713" unitRef="iso4217_USD" decimals="-3">16125000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:LossContingencyDamagesSoughtValue contextRef="eol_PE5753----1110-Q0011_STD_91_20110702_0_456277x487715" unitRef="iso4217_USD" decimals="-5">8500000</us-gaap:LossContingencyDamagesSoughtValue>
  <us-gaap:GrossProfit contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">89949000</us-gaap:GrossProfit>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">445000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:CostOfGoodsSold contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">89496000</us-gaap:CostOfGoodsSold>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">-2447000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">11126000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">19011000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2">0.54</us-gaap:EarningsPerShareDiluted>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">-1566000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">13880000</us-gaap:NetIncomeLoss>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">10350000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">1580000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="shares" decimals="-5">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD_per_shares" decimals="2">0.55</us-gaap:EarningsPerShareBasic>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">18566000</us-gaap:OperatingIncomeLoss>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">179445000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">62613000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">5131000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="shares" decimals="-3">25418000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">-1259000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:OperatingExpenses contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="iso4217_USD" decimals="-3">71383000</us-gaap:OperatingExpenses>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="pure" decimals="3">0.270</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="shares" decimals="-3">25843000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0" unitRef="shares" decimals="-3">425000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x450145" unitRef="iso4217_USD" decimals="-3">147408000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x472622" unitRef="iso4217_USD" decimals="-3">14838000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478709" unitRef="iso4217_USD" decimals="-3">64408000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478711" unitRef="iso4217_USD" decimals="-3">53840000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478711_456277x478706" unitRef="iso4217_USD" decimals="-3">42195000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478711_456277x478707" unitRef="iso4217_USD" decimals="-3">11645000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712" unitRef="iso4217_USD" decimals="-3">29160000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712_456277x478708" unitRef="iso4217_USD" decimals="-3">16206000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712_456277x478714" unitRef="iso4217_USD" decimals="-3">5659000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712_456277x478715" unitRef="iso4217_USD" decimals="-3">7295000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478713" unitRef="iso4217_USD" decimals="-3">17199000</us-gaap:SalesRevenueGoodsNet>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:SoftwareSolutionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712_456277x478715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:OrthopatMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712_456277x478714">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712_456277x478708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:SurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478712">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478711_456277x478707">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:RedCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478711_456277x478706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:PlateletMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x478709">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x472622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:EquipmentAndOtherRelatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0_442428x450145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20111001_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2011-07-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20110702_0_456277x487715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:HighSeparationCoreBowlMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:SoftwareSolutionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712_456277x478715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:OrthopatMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712_456277x478714">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712_456277x478708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:SurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478712">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478711_456277x478707">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:RedCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478711_456277x478706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:PlateletMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x478709">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x472622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:EquipmentAndOtherRelatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0_442428x450145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_91_20101002_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2010-07-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_30_20110930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2011-09-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_454814x454410">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_454814x452760">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_450737x447194">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_449485x455587">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_446729x454493_449485x445999_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_446310x453298">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:SoftwareSolutionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712_456277x478715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:OrthopatMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712_456277x478714">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712_456277x478708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:SurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478712">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478711_456277x478707">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:RedCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478711_456277x478706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:PlateletMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x478709">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x472622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:EquipmentAndOtherRelatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_442428x450145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_446729x478703_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0_441306x451457_446729x454321_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20111001_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:SoftwareSolutionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712_456277x478715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:OrthopatMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712_456277x478714">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712_456277x478708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:SurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478712">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478711_456277x478707">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:RedCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478711_456277x478706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:PlateletMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x478709">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x472622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:EquipmentAndOtherRelatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_442428x450145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0_441306x451457_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_182_20101002_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-10-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20110402_0_451169x442541">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:MortgageLoansOnRealEstateMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20110402_0_450737x447194">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20110402_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20110402_0_441306x451457_451532x449846_452742x468080">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20110402_0_441306x451457_451532x449846_452742x467802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherCurrentAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20110402_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20100403_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-04-03</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20100403_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2010-04-03</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_456277x487715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:HighSeparationCoreBowlMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_451169x442541">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:MortgageLoansOnRealEstateMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_450737x447194">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x452604">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319_453639x441954">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_450407x454319">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_441306x451457_451532x449846_452742x468080">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0_441306x451457_451532x449846_452742x467802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherCurrentAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20111001_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2011-10-01</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20101002_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-10-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0011_STD_0_20101002_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2010-10-02</instant>
    </period>
  </context>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Year">
    <measure>hae:Year</measure>
  </unit>
  <xbrll:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <xbrll:loc xlink:href="#fnid_30437403_1_10" xlink:label="fnid_30437403_1_10" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_11" xlink:label="fnid_30437403_1_11" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_12" xlink:label="fnid_30437403_1_12" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_13" xlink:label="fnid_30437403_1_13" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_14" xlink:label="fnid_30437403_1_14" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_15" xlink:label="fnid_30437403_1_15" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_16" xlink:label="fnid_30437403_1_16" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_18" xlink:label="fnid_30437403_1_18" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_19" xlink:label="fnid_30437403_1_19" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_2" xlink:label="fnid_30437403_1_2" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_20" xlink:label="fnid_30437403_1_20" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_21" xlink:label="fnid_30437403_1_21" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_22" xlink:label="fnid_30437403_1_22" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_23" xlink:label="fnid_30437403_1_23" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_24" xlink:label="fnid_30437403_1_24" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_27" xlink:label="fnid_30437403_1_27" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_28" xlink:label="fnid_30437403_1_28" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_29" xlink:label="fnid_30437403_1_29" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_3" xlink:label="fnid_30437403_1_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_30" xlink:label="fnid_30437403_1_30" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_31" xlink:label="fnid_30437403_1_31" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_32" xlink:label="fnid_30437403_1_32" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_33" xlink:label="fnid_30437403_1_33" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_34" xlink:label="fnid_30437403_1_34" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_35" xlink:label="fnid_30437403_1_35" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_36" xlink:label="fnid_30437403_1_36" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_37" xlink:label="fnid_30437403_1_37" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_39" xlink:label="fnid_30437403_1_39" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_4" xlink:label="fnid_30437403_1_4" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_40" xlink:label="fnid_30437403_1_40" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_41" xlink:label="fnid_30437403_1_41" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_42" xlink:label="fnid_30437403_1_42" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_43" xlink:label="fnid_30437403_1_43" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_44" xlink:label="fnid_30437403_1_44" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_45" xlink:label="fnid_30437403_1_45" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_46" xlink:label="fnid_30437403_1_46" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_47" xlink:label="fnid_30437403_1_47" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_48" xlink:label="fnid_30437403_1_48" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_5" xlink:label="fnid_30437403_1_5" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_6" xlink:label="fnid_30437403_1_6" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_7" xlink:label="fnid_30437403_1_7" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437403_1_8" xlink:label="fnid_30437403_1_8" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437438_1001_1" xlink:label="fnid_30437438_1001_1" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437438_1002_1" xlink:label="fnid_30437438_1002_1" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_30437438_1003_1" xlink:label="fnid_30437438_1003_1" xlink:type="locator"/>
    <xbrll:footnote xlink:label="footnote_30437418" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">We exclude the difference between the spot rate and hedge forward rate from our effectiveness testing.</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_30437419" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(unaudited)</xbrll:footnote>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_10" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_11" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_12" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_13" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_14" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_15" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_16" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_18" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_19" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_2" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_20" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_21" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_22" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_23" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_24" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_27" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_28" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_29" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_3" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_30" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_31" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_32" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_33" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_34" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_35" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_36" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_37" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_39" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_4" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_40" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_41" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_42" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_43" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_44" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_45" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_46" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_47" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_48" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_5" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_6" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_7" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437403_1_8" xlink:to="footnote_30437419" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437438_1001_1" xlink:to="footnote_30437418" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437438_1002_1" xlink:to="footnote_30437418" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_30437438_1003_1" xlink:to="footnote_30437418" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
  </xbrll:footnoteLink>
</xbrl>
</XBRL>
